A 2018 review of 16 studies of cannabis-centered medicines for neuropathic discomfort, the majority of which examined a cannabinoid preparing termed nabiximols (brand name Sativex; a mouth spray that contains equally THC and CBD that may be authorised in some international locations but not in the United States), discovered low- to moderate-high qu